Schedule for Master Class Live In Person

All times listed below are Central Time. Please adjust accordingly for your timezone.

October 21, 2022

  • 6:45am - 7:15am

    Registration and Breakfast

  • 7:15am - 7:25am

    Welcome and Opening Remarks

Session 1 - Malignant and Non-Malignant Hematology

Moderator: Jean M. Connors MD

  • 7:25am - 8:10am

    Non-Hodgkin and Hodgkin Lymphoma: An Individualized Treatment Approach

    Ann S. LaCasce MD, MMSC
  • 8:10am - 8:55am

    Myeloid Malignancies: Molecular Markets and Targeted Therapies

    Daniel J. DeAngelo, MD, PhD
  • 8:55am - 9:20am

    Molecular Drivers of Myeloproliferative Neoplasms: Impact on Diagnosis, Assessment, and Management

    Ayalew Tefferi, MD
  • 9:20am - 9:45am

    Multiple Myeloma: Current Evidence-Based Management

    Kenneth C. Anderson, MD
  • 9:45am - 10:10am

    Chronic Lymphocytic Leukemia: Evaluating the Rapidly Changing Treatment Landscape

    Matthew S. Davids MD, MMSC
  • 10:10am - 10:25am

    Refreshment Break

  • 10:25am - 10:55am

    Current and Future Treatment Strategies for Cancer Associated Thrombosis

    Jean M. Connors MD
  • 10:55am - 11:25am

    Reducing the Sickle Cell Disease Burden with Novel Treatment Targets

    Alexis A. Thompson MD, MPH
  • 11:25am - 12:00pm

    Panel Discussion

    All Faculty
  • 12:00pm - 12:45pm


October 21, 2022

Session 2 – Women’s Cancers and Supportive Care

Moderator: Harold J. Burstein MD, PhD

Supportive Care

  • 12:45pm - 1:10pm

    Sexual Health in Cancer Survivors

    Sharon L. Bober, PhD
  • 1:10pm - 1:35pm

    Supportive and Palliative Care: Managing Symptoms and Toxicities to Improve Patient Outcomes

    Janet L. Abrahm, MD
  • 1:35pm - 1:55pm

    Supportive Care Questions and Answers

  • 1:55pm - 2:10pm

    Refreshment Break

Breast Cancers

  • 2:10pm - 2:50pm

    HER2-Positive Breast Cancer and Triple-Negative Breast Cancer: An Evolving Treatment Landscape

    Nancy U. Lin MD
  • 2:50pm - 3:15pm

    Advances in Hormone Receptor Positive Breast Cancer and Hereditary Breast Cancer Syndromes

    Harold J. Burstein MD, PhD

Gynecologic Cancers

  • 3:30pm - 4:00pm

    Molecular Advances and Emerging Treatment Strategies In Ovarian Cancer

    Ursula A. Matulonis, MD
  • 4:00pm - 4:25pm

    Molecular Advances and Emerging Treatment Strategies In Endometrial Cancer

    Joyce F. Liu, MD, MPH
  • 4:25pm - 4:55pm

    Panel Discussion

    All Faculty
  • 4:55pm

    Day One Adjournment

October 22, 2022

  • 6:45am - 7:15am

    Registration and Breakfast

  • 7:15am - 7:20am

    Welcome Back

Session 3 – Gastrointestinal Cancers and Sarcoma

Moderator: Robert J. Mayer MD

Gastrointestinal Cancers

  • 7:20am - 8:05am

    Colorectal Cancer: Molecular Markers and Evidence-Based Best Practices for Systemic Treatment

    Robert J. Mayer MD
  • 8:05am - 8:25am

    Novel Treatments for Neuroendocrine Tumors: Using Patient and Tumor Characteristics to Guide Treatments

    Jennifer A. Chan, MD, MPH
  • 8:25am - 9:10am

    Novel Approaches for the Management of Esophageal, Gastric, and Pancreatic Cancers

    Peter C. Enzinger, MD
  • 9:10am - 9:30am

    Hepatobiliary Cancer: Predictive Biomarkers, Novel Agents, and Patient Monitoring

    Thomas A. Abrams, MD
  • 9:30am - 9:45am

    Refreshment Break

  • 9:45am - 10:25am

    Hereditary Gastrointestinal Cancers: From Family History to Management with Combination Therapy

    Matthew B. Yurgelun, MD
  • 10:25am - 10:55am

    Panel Discussion

    All Faculty


  • 10:55am - 11:25am

    Best Practices and Expanding Treatment Options in Soft Tissue Sarcoma

    George D. Demetri, MD
  • 11:25am - 11:35am

    Sarcoma Questions and Answers

  • 11:35am - 12:20pm


October 22, 2022

Session 4 – Head, Neck and Lung Cancers and Melanoma

Moderator: Bruce E. Johnson MD

Head, Neck and Lung Cancers

  • 12:20pm - 1:00pm

    Emerging Agents in the Multimodal Management of Head, Neck, and Thyroid Cancers

    Robert I. Haddad, MD
  • 1:00pm - 1:50pm

    NSCLC and SCLC: Molecular Testing and Emerging Treatment Options

    Bruce E. Johnson MD

Melanoma Cancer

  • 1:50pm - 2:25pm

    Evidence-Based Treatment Approaches for Adjuvant, Advanced, and Metastatic Melanoma

    F. Stephen Hodi, MD
  • 2:25pm - 2:55pm

    Panel Discussion

    All Faculty
  • 2:55pm - 3:10pm

    Refreshment Break

October 22, 2022

Session 5 – Genitourinary Cancers

Moderator: Bruce E. Johnson MD

  • 3:10pm - 4:00pm

    Prostate Cancer: An Evolving Treatment Landscape

    Mary Ellen Taplin, MD
  • 4:00pm - 4:35pm

    Treatment Selection in Renal Cell and Urothelial Carcinoma: Integrating Novel Agents into Daily Practice

    Robert Dreicer, MD
  • 4:35pm - 5:05pm

    Panel Discussion

    All Faculty
  • 5:05pm - 5:10pm

    Closing Remarks

  • 5:10pm

    Course Adjournment